Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 4/2018

03.04.2018 | Short Communication

Altered Red Cell Indices in Repeat Blood Donors: Experience of a North Indian Blood Bank

verfasst von: Ashish Jain, Nilotpal Chowdhury, Sanchit Jain, Nikita Uttam, Sushant Kumar Meinia

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Subclinical Iron deficiency appearing in blood donors after blood donation is a recognized problem. Donors at an increased risk of iron deficiency need to be identified. Blood donors meeting national selection criteria were included in the study. Complete blood counts were done using Sysmex XP-100 three part hematology analyzer. Differences in RBC indices among donor groups defined by previous donations were then analyzed statistically. Six hundred and seventy three males and ninety six females were studied. In males, Kruskal–Wallis test showed significant differences between groups defined by number of donations for MCH and MCV (P value < 0.001), but not for MCHC (P value = 0.09) and RDW (P value = 0.6). Post-hoc tests showed statistically significant difference between donors having six or more donations compared to donors having no previous donations for both MCH as well as MCV. No significant difference was found between donor subgroups in females for any of the indices; however, no female donated blood more than three times in the study. There is increased risk for iron deficiency in donors having six or more previous donations, and evidence for starting an iron screening and supplementation programme for these donors.
Literatur
1.
Zurück zum Zitat Nadarajan V, Sthaneshwar P, Eow GI (2008) Use of red blood cell indices for the identification of iron deficiency among blood donors. Transfus Med 18(3):184–189CrossRef Nadarajan V, Sthaneshwar P, Eow GI (2008) Use of red blood cell indices for the identification of iron deficiency among blood donors. Transfus Med 18(3):184–189CrossRef
2.
Zurück zum Zitat Alexander HD, Sherlock JP, Bharucha C (2000) Red cell indices as predictors of iron depletion in blood donors. Clin Lab Haematol 22(5):253–258CrossRef Alexander HD, Sherlock JP, Bharucha C (2000) Red cell indices as predictors of iron depletion in blood donors. Clin Lab Haematol 22(5):253–258CrossRef
3.
Zurück zum Zitat Kiss JE, Steele WR, Wright DJ, Mast AE, Carey PM, Murphy EL et al (2013) Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion 53(11):2766–2775CrossRef Kiss JE, Steele WR, Wright DJ, Mast AE, Carey PM, Murphy EL et al (2013) Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion 53(11):2766–2775CrossRef
4.
Zurück zum Zitat National AIDS Control Organization (2007) Standards for blood banks and blood transfusion services. New Delhi: National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India National AIDS Control Organization (2007) Standards for blood banks and blood transfusion services. New Delhi: National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India
5.
Zurück zum Zitat Mentzer WC (1973) Differentiation of iron deficiency from thalassaemia trait. Lancet (London, England) 1(7808):882CrossRef Mentzer WC (1973) Differentiation of iron deficiency from thalassaemia trait. Lancet (London, England) 1(7808):882CrossRef
6.
Zurück zum Zitat Lafferty JD, Crowther MA, Ali MA, Levine M (1996) The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and non-thalassemic microcytosis. Am J Clin Pathol 106(2):201–205CrossRef Lafferty JD, Crowther MA, Ali MA, Levine M (1996) The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and non-thalassemic microcytosis. Am J Clin Pathol 106(2):201–205CrossRef
7.
Zurück zum Zitat Rathod DA, Kaur A, Patel V, Patel K, Kabrawala R, Patel V et al (2007) Usefulness of cell counter-based parameters and formulas in detection of β-thalassemia trait in areas of high prevalence. Am J Clin Pathol 128(4):585–589CrossRef Rathod DA, Kaur A, Patel V, Patel K, Kabrawala R, Patel V et al (2007) Usefulness of cell counter-based parameters and formulas in detection of β-thalassemia trait in areas of high prevalence. Am J Clin Pathol 128(4):585–589CrossRef
8.
Zurück zum Zitat Hoffbrand AV, Moss PAH (2016) Hoffbrand’s essential haematology, 7th edn. Wiley, Chichester Hoffbrand AV, Moss PAH (2016) Hoffbrand’s essential haematology, 7th edn. Wiley, Chichester
9.
Zurück zum Zitat R Core Team (2014) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Core Team (2014) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
10.
Zurück zum Zitat Pohlert T (2014) The pairwise multiple comparison of mean ranks package (PMCMR). R Package Pohlert T (2014) The pairwise multiple comparison of mean ranks package (PMCMR). R Package
11.
Zurück zum Zitat Aragon TJ (2012) Epitools: epidemiology tools. R package version 0.5-7 Aragon TJ (2012) Epitools: epidemiology tools. R package version 0.5-7
12.
Zurück zum Zitat Aulakh R, Sohi I, Singh T, Kakkar N (2009) Red cell distribution width (RDW) in the diagnosis of iron deficiency with microcytic hypochromic anemia. Indian J Pediatr 76(3):265–268CrossRef Aulakh R, Sohi I, Singh T, Kakkar N (2009) Red cell distribution width (RDW) in the diagnosis of iron deficiency with microcytic hypochromic anemia. Indian J Pediatr 76(3):265–268CrossRef
13.
Zurück zum Zitat Sultana GS, Haque SA, Sultana T, Ahmed AN (2013) Value of red cell distribution width (RDW) and RBC indices in the detection of iron deficiency anemia. Mymensingh Med J 22(2):370–376PubMed Sultana GS, Haque SA, Sultana T, Ahmed AN (2013) Value of red cell distribution width (RDW) and RBC indices in the detection of iron deficiency anemia. Mymensingh Med J 22(2):370–376PubMed
14.
Zurück zum Zitat Mahida VI, Bhatti A, Gupte SC (2008) Iron status of regular voluntary blood donors. Asian J Transfus Sci 2(1):9–12CrossRef Mahida VI, Bhatti A, Gupte SC (2008) Iron status of regular voluntary blood donors. Asian J Transfus Sci 2(1):9–12CrossRef
15.
Zurück zum Zitat Mittal R, Marwaha N, Basu S, Mohan H, Ravi Kumar A (2006) Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res 124(6):641–646PubMed Mittal R, Marwaha N, Basu S, Mohan H, Ravi Kumar A (2006) Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res 124(6):641–646PubMed
Metadaten
Titel
Altered Red Cell Indices in Repeat Blood Donors: Experience of a North Indian Blood Bank
verfasst von
Ashish Jain
Nilotpal Chowdhury
Sanchit Jain
Nikita Uttam
Sushant Kumar Meinia
Publikationsdatum
03.04.2018
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2018
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0954-9

Weitere Artikel der Ausgabe 4/2018

Indian Journal of Hematology and Blood Transfusion 4/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.